Reviva Pharmaceuticals Holdings, Inc. (RVPH) Q3 2024 Earnings
RVPH·Reported November 14, 2024·Before market open
Diluted EPS came in at $-0.25, missed the $-0.23 consensus by $0.02.
Diluted EPS
$-0.25missed by $0.02
Consensus: $-0.23
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Reviva Pharmaceuticals Holdings, Inc.'s Q3 2024 earnings report.
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Q3 2024 earnings on November 14, 2024 before market open.
Reviva Pharmaceuticals Holdings, Inc. reported diluted EPS of $-0.25 for Q3 2024.
EPS missed the consensus estimate of $-0.23 by $0.02.
You can read the 10-Q periodic report (0001437749-24-035375) directly on SEC EDGAR. The filing index links above go to sec.gov.